ANGPTL-6, also called angiopoietin-related growth factor protein 5 (ARP5), initially known as a circulating proangiogenic factor mainly secreted from the liver [36–38], represents an attractive therapeutic target for anti-tumor therapy [39]. The gene discussed is ANGPTL6; the disease is neoplasm.